The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening.

Liquid biopsy developer Freenome and Medtech giant Siemens Healthineers are putting their heads together for just that purpose. Researchers from both companies will team up with a goal of identifying potential new targets for a blood test that could ultimately be administered alongside mammograms and other diagnostic imaging techniques to improve early detection of breast cancer.

Read the full article at